Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-3-6
pubmed:abstractText
To evaluate the efficacy and safety of four doses of pioglitazone monotherapy in the treatment of patients with type 2 diabetes.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1605-11
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11092281-Adult, pubmed-meshheading:11092281-Aged, pubmed-meshheading:11092281-Blood Glucose, pubmed-meshheading:11092281-C-Peptide, pubmed-meshheading:11092281-Continental Population Groups, pubmed-meshheading:11092281-Diabetes Mellitus, Type 2, pubmed-meshheading:11092281-Dose-Response Relationship, Drug, pubmed-meshheading:11092281-Double-Blind Method, pubmed-meshheading:11092281-Ethnic Groups, pubmed-meshheading:11092281-Female, pubmed-meshheading:11092281-Hemoglobin A, Glycosylated, pubmed-meshheading:11092281-Humans, pubmed-meshheading:11092281-Hypoglycemic Agents, pubmed-meshheading:11092281-Male, pubmed-meshheading:11092281-Middle Aged, pubmed-meshheading:11092281-Placebos, pubmed-meshheading:11092281-Thiazoles, pubmed-meshheading:11092281-Thiazolidinediones, pubmed-meshheading:11092281-United States
pubmed:year
2000
pubmed:articleTitle
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
pubmed:affiliation
Research Institute of Dallas, Texas, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study